SCHEMBL4343603

SCHEMBL4343603

CC(C)OC(Cc1ccc(CNC(=O)OCc2ccc(Cl)cc2Cl)cc1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.47
PPARA Q07869 6/20 0.42
HTT P42858 3/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
THRB P10828 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PPARG P37231 5/20 0.42
PPARD Q03181 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
GALR3 O60755 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
TSHR P16473 1/20 0.40
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39
NLRP1 Q9C000 1/20 0.39
ERCC1 P07992 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13810608 0.92 LMNA (0.44) GAAPPARAALDH1A1L3MBTL1PPARG
SCHEMBL4328023 0.91 GAA (0.44) GAAPPARAHTTKMT2AMEN1
SCHEMBL4335925 0.89 LMNA (0.45) PPARAHTTKMT2AMEN1ALDH1A1
SCHEMBL4328778 0.88 GAA (0.47) GAAPPARAHTTKMT2AMEN1
SCHEMBL4333276 0.87 PPARG (0.48) PPARAALDH1A1PPARGPPARDSMN1; SMN2
SCHEMBL13810610 0.87 PPARG (0.48) PPARAALDH1A1PPARGPPARDSMN1; SMN2
SCHEMBL4329108 0.83 PPARA (0.40) PPARAALDH1A1PPARGPPARDSMN1; SMN2
SCHEMBL4329105 0.83 PPARA (0.40) PPARAALDH1A1PPARGPPARDSMN1; SMN2
SCHEMBL4339331 0.82 ATM (0.46) PPARAL3MBTL1PPARGPPARDLMNA
SCHEMBL4333374 0.82 PPARA (0.46) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 GAA 2303/4885PPARA 339/4885HTT 3749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.